Clinical Trial Update: Daily Protein Intake Distribution and MPS (ARCIII) [NA]

View source ↗

Summary

A completed clinical trial led by Nestlé investigated daily protein intake distribution and muscle protein synthesis (ARCIII) in overweight individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overweight

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Overweight | NA | Status: COMPLETED